Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Radio-opaque Contrast Agents for Liver Cancer Targeting With KIM During Radiation Therapy

NCT05169177 is registered in ClinicalTrials.gov with University of Sydney as lead sponsor.

NCT NCT05169177
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05169177 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Radio-opaque Contrast Agents for Liver Cancer Targeting With KIM During Radiation Therapy
Lead sponsor
University of Sydney
Phase
Observational
Overall status
Recruiting
Start date
October 17, 2022
Completion date
October 31, 2026
Enrollment
50 (estimated)
Sites
5

Conditions

As the registry lists them; a condition with its own page is linked.

liver neoplasm